Skip to content

Clinical trials

Observational Spondylarthritis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Spondylarthritis Phase: Observational Clear all

90 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20043
20051
20062
20071
20091
20113
20121
20133
20158
20163
20174
20184
20195
20208
202111
20226
20235
20243
20258
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Unknown status18
Recruiting16
Not yet recruiting8
Active, not recruiting4
Terminated3
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris9
Centre Hospitalier Universitaire de Nice5
Diakonhjemmet Hospital5
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)5
University Hospital, Grenoble3
University Hospital, Montpellier3
Centre Hospitalier Universitaire de Nīmes2
Charite University, Berlin, Germany2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
Hospital for Special Surgery, New York2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Spondylarthritis90
Arthritis, Rheumatoid37
Spondylitis, Ankylosing22
Arthritis, Psoriatic21
Arthritis9
Spondylarthropathies8
Arthritis, Juvenile6
Axial Spondyloarthritis5
Behcet Syndrome5
Crohn Disease5

Trials

Showing 76 to 90 of 90. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.